Academia.edu no longer supports Internet Explorer.
To browse Academia.edu and the wider internet faster and more securely, please take a few seconds to upgrade your browser.
2001, Sexually Transmitted Diseases
…
4 pages
1 file
Background: A topical microbicide should protect against acquisition of sexually transmitted infection during both vaginal and rectal intercourse. The rectal microflora of the Macaca nemestrina (pig-tailed macaque) and humans were examined, as well as the histopathology of rectal tissues. In a subset of macaques, a human rectal isolate of Chlamydia trachomatis was inoculated into the rectum to establish rectal chlamydial infection. Goal: To evaluate the comparability of the pig-tailed macaque rectal model with humans. Study Design: Rectal swabs were collected for microbiologic analysis to characterize normal microflora in pig-tailed macaques and humans. Subsequently, 10 macaques received a rectal inoculation with C trachomatis, serovar D, prepared from a clinical rectal isolate. Results: The rectal microflora of pig-tailed macaques (n ؍ 80) were found to be comparable with the rectal flora of humans (n ؍ 40). The prevalence of Lactobacillus in the rectum was higher in the macaques than in humans. Coliform and Enterococcus were decreased in the macaques, as compared with those of humans. In 9 of 10 macaques, rectal chlamydial infection was confirmed by culture or ligase chain reaction on days 2, 7, and 14 after inoculation. The test results were positive for rectal chlamydial infection by ligase chain reaction only for the remaining animal on day 14 after inoculation. Conclusions: The findings demonstrate that the rectal environment of the pig-tailed macaque is a useful model for further evaluation of newly developed topical microbicides for rectal use. Furthermore, such products can be evaluated for protection against rectal chlamydial infection in this model.
Sexually Transmitted Diseases, 2004
Background: The nonhuman primate model allows for safety and efficacy testing of topical microbicide products. Goal: The goal of this study was to evaluate the safety and efficacy of vaginal and rectal applications of BufferGel (ReProtect, Inc.). Study Design: The safety of repeated product applications was evaluated by microflora, pH, vaginal colposcopy, and rectal lavage. To test efficacy in preventing chlamydia, infection was documented by culture and nucleic acid amplification tests. Results: Repeated vaginal or rectal applications of BufferGel were not associated with significant changes in microflora. BufferGel use had a transient acidifying effect on vaginal and rectal pH. Colposcopic observations remained relatively normal in all test animals. A slightly increased incidence of epithelial desquamation was noted after rectal product use compared with the control group. BufferGel did not prevent cervical or rectal chlamydial infection. Conclusion: BufferGel has an acceptable safety profile after repeated vaginal and rectal use, but does not prevent chlamydial infection in the macaque models. THE NEED TO DEVELOP topical microbicides for intravaginal and intrarectal use that can prevent infection by HIV and other sexually transmitted infections (STIs) is compelling. As such products are developed, preclinical safety evaluations in appropriate experimental models are essential. Topical microbicide products are intended to provide protection from STIs while residing on the cervicovaginal and/or rectal epithelium. Product-induced irritation and ulceration of vaginal or rectal epithelium could facilitate acquisition and transmission of HIV and other STIs. Such toxic tissue responses would likely prevent an otherwise effective topical microbicide from gaining approval for human use. It is essential that a formulated topical microbicide product, which is likely to be applied multiple times by the user, be shown to have an acceptable safety profile after repeated product use. We have developed and documented the use of the pigtailed macaque for safety evaluations of topical microbicide products for intravaginal and intrarectal use. 1-6 Nonoxynol-9 was found to cause damage to the rectal epithelium both in humans 7,8 and in the monkey model. 6 Limited data from nonprimate animal models is available for BufferGel (ReProtect, Inc.). 9 In this study, we first assessed the safety profile of repeated vaginal and rectal applications of BufferGel, an acidifying agent. Second, the chlamydiacidal activity of BufferGel was investigated both vaginally and rectally in this animal model. Methods and Materials Experimental Animals Research breeding-aged, female Macaca nemestrina were obtained from colony animals at the Washington National Primate Research Center for assignment to this study. Prior approval for use of monkeys in this protocol was obtained from the Institutional Animal Care and Use Committee at the University of Washington. Animals were handled humanely, and experiments were carried out according to the Animal Use Guidelines of the National Institutes of Health. Animals were intramuscularly anesthetized with ketamine/atropine or Telazol for all procedures.
Journal of Medical Primatology, 2011
Background-Inclusion of sexual activity in the macaque model for topical microbicide safety evaluation would more closely mimic human use of topical microbicides and provide a more rigorous safety assessment. Methods-Initially male-female partners were monitored in co-housing arrangements to determine whether macaques would copulate ad libitum. The logistics of performing vaginal exams before and after coital visits were analyzed and optimized. Findings from cervicovaginal exams conducted before and after sexual activity were compared. Results-Coital activity was reliably observed in the majority of co-housing sessions, representing all phases of the menstrual cycle. Female macaques were trained to be restrained while fully alert for pre-coital vaginal sampling. Post coital exams occur under general sedation. Post-coital exams reveal alterations to tissues, microbiology and pH compared to pre-coital visits. Conclusions-This work clearly demonstrates that it is feasible to incorporate sexual activity in the macaque model for topical microbicide safety assessment.
Journal of Medical Primatology, 2009
Background-We sought to establish a nonhuman primate model of vaginal Lactobacillus colonization suitable for evaluating live microbial microbicide candidates. Methods-Vaginal and rectal microflora in Chinese rhesus macaques (Macaca mulatta) were analyzed, with cultivable bacteria identified by 16S rRNA gene sequencing. Live lactobacilli were intravaginally administered to evaluate bacterial colonization. Results-Chinese rhesus macaques harbored abundant vaginal Lactobacillus, with Lactobacillus johnsonii as the predominant species. Like humans, most examined macaques harbored only one vaginal Lactobacillus species. Vaginal and rectal Lactobacillus isolates from the same animal exhibited different genetic and biochemical profiles. Vaginal Lactobacillus was cleared by a vaginal suppository of azithromycin, and endogenous L. johnsonii was subsequently restored by intravaginal inoculation. Importantly, prolonged colonization of a human vaginal Lactobacillus jensenii was established in these animals. Conclusions-The Chinese rhesus macaque harbors vaginal Lactobacillus and is a potentially useful model to support the pre-clinical evaluation of Lactobacillus-based topical microbicides.
Journal of Medical Primatology, 2012
Journal of Medical Primatology, 2017
Background-Rhesus and cynomologus macaques are valuable animal models for the study of Human Immunodeficiency Virus (HIV) prevention strategies. However, for such studies focused on the vaginal route of infection, differences in vaginal environment may have deterministic impact on the outcome of such prevention, providing the rationale for this study. Methods-We tested the vaginal environment of rhesus and cynomolgus macaques longitudinally to characterize the normal microflora based on Nugent scores and pH. This evaluation was extended after colonization of the vaginal space with Lactobacilli in an effort to recreate NHP models representing the healthy human vaginal environment. Results and Conclusion-Nugent scores and pH differed significantly between species, though data from both species were suggestive of stable bacterial vaginosis. Colonization with Lactobacilli was successful in both species leading to lower Nugent score and pH, though rhesus macaques appeared better able to sustain Lactobacillus spp over time.
AIDS Research and Human Retroviruses, 2012
Vaginal bacterial communities play an important role in human health and have been shown to influence HIV infection. Pigtailed macaques (Macaca nemestrina) are used as an animal model of HIV vaginal infection of women. Since the bacterial microbiota could influence retrovirus infection of pigtailed macaques, the genital microbiota in 10 cycling macaques was determined by pyrosequencing. The microbiota of all macaques was polymicrobial with a median of 13 distinct genera. Strikingly, the genera Sneathia and Fusobacterium, both in the phylum Fusobacteria, accounted for 18.9% and 13.3% of sequences while the next most frequent were Prevotella (5.6%), Porphyromonas (4.1%), Atopobium (3.6%), and Parvimonas (2.6%). Sequences corresponding to Lactobacillus comprised only 2.2% of sequences on average and were essentially all L. amylovorus. Longitudinal sampling of the 10 macaques over an 8-week period, which spanned at least one full ovulatory cycle, showed a generally stable presence of the major types of bacteria with some exceptions. These studies show that the microbiota of the pigtailed macaques is substantially dissimilar to that found in most healthy humans, where the genital microbiota is usually dominated by Lactobacillus sp. The polymicrobial makeup of the macaque bacterial populations, the paucity of lactobacilli, and the specific types of bacteria present suggest that the pigtailed macaque microbiota could influence vaginal retrovirus infection.
Sexually Transmitted Diseases, 2002
Background: Microbicides are being developed for womancontrolled protection against sexually transmitted diseases (STDs). Goal: The goal of the study was to test candidate microbicides in a mouse model for preventing vaginal transmission of Chlamydia trachomatis and for acute toxicity to columnar epithelium. Study Design: Progestin-sensitized CF-1 mice were treated vaginally with 50 l of microbicide, followed either by vaginal inoculation with 10 ID 50 of C trachomatis serovar D or by examination of the epithelial surface for acute toxicity with a viability stain (ethidium homodimer-1). Results: Nonoxynol-9 (N9), sodium dodecyl sulfate (SDS), chlorhexidine digluconate, and BufferGel all provided significant though incomplete protection against vaginal transmission. Other candidates, all of which were effective in vitro, provided no vaginal protection:-carrageenan, dextran sulfate, polystyrene sulfonate, Concanavalin A, wheat germ agglutinin, and Phaseolus vulgaris agglutinin. The surface-active agents (N9, SDS, and chlorhexidine) caused significant acute epithelial toxicity: 3 days after chlorhexidine exposure, mice also had vaginal friability and markedly increased susceptibility to Chlamydia. BufferGel was the only candidate tested that was both protective and relatively nontoxic. Conclusion: Microbicides can provide vaginal protection against Chlamydia in highly susceptible progestin-sensitized mice. Since N9 does not inactivate Chlamydia, it likely protects by killing target cells in the vagina. Despite the ability to both potently inactivate Chlamydia and kill target cells, two surfaceactive agents, SDS and chlorhexidine, failed to provide complete protection, a circumstance which emphasizes the importance of distributing microbicides to all susceptible surfaces. Hughes Medical Institute (to P. B. S.).
Mathematical Biosciences and Engineering, 2006
We evaluate the potential impact of rectal microbicides for reducing HIV transmission in bathhouses. A new mathematical model describing HIV transmission dynamics among men who have sex with men (MSM) in bathhouses is constructed and analyzed. The model incorporates key features affecting transmission, including: sexual role behavior (insertive and receptive anal intercourse acts), biological transmissibility of HIV, frequency and efficacy of condom usage, and, most pertinently, frequency and efficacy of rectal microbicide usage. To evaluate the potential impact of rectal microbicide usage, we quantify the effect of rectal microbicides (ranging in efficacy from 10% to 90%) on reducing the number of HIV infections in the bathhouse. We conduct uncertainty analyses to assess the effect of variability in both biological and behavioral parameters. We find that even moderately effective rectal microbicides (if used in 10% to 50% of the sex acts) would substantially reduce transmission in bathhouses. For example, a 50% effective rectal microbicide (used in 50% of sex acts) would reduce the number of secondary infections by almost 13% at disease invasion . Our modeling analyses show that even moderately effective rectal microbicides could be very effective prevention tools for reducing transmission in bathhouses, and also potentially limit the spread of HIV in the community.
Antimicrobial Agents and Chemotherapy, 2004
Commonly used “inactive” pharmaceutical excipients were tested in a previously developed minimum cidal concentration assay to assess their ability to kill Chlamydia trachomatis topically. Sixteen excipients were evaluated in these studies under various conditions. A range of activities was found among the excipients that could be tested in our assay system.
Anatomía humana, descriptiva, topográfica y funcional (tomo 1 cabeza y cuello ), 2005
ورقة بحثية مقدمة في مؤتمر دولي حول حقوق الإنسان , 2021
Series Byzantina, 2017
الحدائق النباتية وتاريخ الزراعة المصرية - نبذة تاريخية وأهميتها العلمية, 2021
Contribuciones a Las Ciencias Sociales, 2024
Anuario Colombiano de Historia Social y de la Cultura, 2013
Ecologia Politica, 2003
Journal of Materials Science: Materials in Electronics, 2013
Addiction (Abingdon, England), 2016
Pesquisa Agropecuaria Tropical, 2007
Annales Polonici Mathematici, 1991
2020
Heart, Lung and Circulation
Annals of translational medicine, 2018